Search
BridgeBio Pharma Inc
BBIOAdd to Watchlist
69.430USD
+0.070+0.10%
Market hours （ET）Quotes delayed by 15 min
13.59BMarket Cap
LossP/E TTM
BridgeBio Pharma Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
502.08M
126.26%
EPS(YoY)
-3.79
-31.46%
Analyst Rating
BUY
2026-06-24
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total revenue reached 502.08M, with a year-on-year change of 126.26.
What are the current assets of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its current assets were 797.75M, with a year-on-year change of 10.69.
What are the total assets of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total assets of BridgeBio Pharma Inc were 936.02M, with a year-on-year change of 1.82.
What are the total liabilities of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total liabilities of BridgeBio Pharma Inc were 3.01B, with a year-on-year change of 26.74.
What is the total equity of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its total equity of BridgeBio Pharma Inc was -2.08B, with a year-on-year change of -42.46.
What is the net investment of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net investment of BridgeBio Pharma Inc was -24.49M, with a year-on-year change of -140.29.
What is the net financing of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net financing of BridgeBio Pharma Inc was 359.29M, with a year-on-year change of -52.00.
What is the Earnings Per Share (EPS) of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.79, with a year-on-year change of -31.46.
What is the net margin of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its net profit margin was -145.98, with a year-on-year change of 40.38.
What is the gross margin of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its gross margin was 95.82, with a year-on-year change of -2.47.
What is the debt-to-asset ratio of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its debt-to-asset ratio was 289.26, with a year-on-year change of 20.85.
What is the Return on Assets (ROA) of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -79.01, with a year-on-year change of -6.56.
What is the operating profit of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2025 earnings report, its operating profit was -502.06M, with a year-on-year change of 13.04.
